NEW YORK, NY / ACCESSWIRE / November 12, 2018 / U.S. markets plunged Friday, with the Dow dropping over 200 points, as falling oil prices raised global economic concerns. Prices for West Texas Intermediate crude for December delivery has slid into bear market territory from almost a 4 year high in just 5 weeks. The Dow Jones Industrial Average dropped 0.77 percent to close at 25,989.30, while the S&P 500 Index shed 0.92 percent to close at 2,781.01. The Nasdaq Composite Index decreased 1.65 percent higher to close at 7,406.90.
According to Willie Delwiche, investment strategist at R.W. Baird, “Oil being down could be a sign that the global economy is in a tough spot.” “The initial reaction to lower oil prices has been that they’ll be a boon for the middle class,” Delwiche said that the view could be inaccurate considering that consumer confidence doesn’t have more chances to grow, and because a smaller part of the American consumer’s budget goes to gasoline than it has in the previous years.
“That’s a new reality that has to be reckoned with, and if this is a replay of the [oil price crash] of 2015 and 2016, it could have a meaningful impact on U.S. investment and earnings,” he added.
RDI Initiates Coverage on:
DexCom's stock moved 0.71% higher Friday, to close the day at $149.46. The stock recorded a trading volume of 1,601,506 shares, which was above its three months average volume of 1,157,140 shares. In the last year, DexCom's shares have traded in a range of 50.09 - 152.14. The share price has gained 198.38% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $132.03 is above its 200-day moving average of $113.64. Shares of DexCom have gained roughly 22.11 percent in the past month and are up 160.43 percent year-to-date.
Access RDI's DexCom, Inc. Research Report at:
On Friday, shares of BioTelemetry recorded a trading volume of 958,585 shares, which was above the three months average volume of 491,562 shares. The stock ended the day 1.9% lower at $68.15. The share price has fallen 2.64% from its 52 week high with a 52 week trading range of 23.30 - 70.00. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $57.98 is above its 200-day moving average of $51.60. Shares of BioTelemetry have gained roughly 31.64 percent in the past month and are up 127.93 percent year-to-date.
Access RDI's BioTelemetry, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.